Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117. State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Case and Commentary Sep 2021 What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? Jeffrey R. Botkin, MD, MPH Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research. AMA J Ethics. 2021;23(9):E685-691. doi: 10.1001/amajethics.2021.685. Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy." Case and Commentary Oct 2023 What Should Be the Scope of Long-Term Care Organizations’ Obligations to Offer Culturally and Linguistically Appropriate Services to Patients? Darlon Jan, MD, Azziza Bankole, MD, and Mamta Sapra, MBBS Despite legal protections for services for patients with LEP, some places have limited capacity to offer them. AMA J Ethics. 2023;25(10):E733-739. doi: 10.1001/amajethics.2023.733. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117.
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Sep 2021 What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? Jeffrey R. Botkin, MD, MPH Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research. AMA J Ethics. 2021;23(9):E685-691. doi: 10.1001/amajethics.2021.685.
Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy."
Case and Commentary Oct 2023 What Should Be the Scope of Long-Term Care Organizations’ Obligations to Offer Culturally and Linguistically Appropriate Services to Patients? Darlon Jan, MD, Azziza Bankole, MD, and Mamta Sapra, MBBS Despite legal protections for services for patients with LEP, some places have limited capacity to offer them. AMA J Ethics. 2023;25(10):E733-739. doi: 10.1001/amajethics.2023.733.